Lamotrigine Mylan (Lamotrigine)

Lamotrigine is used in the management of seizure disorders and mood stabilization, acting on neuronal excitability.

• Epilepsy: Reduces frequency and severity of partial and generalized seizures.
• Bipolar disorder: Helps prevent recurrence of depressive and manic episodes.
• Lennox‑Gastaut syndrome: Provides adjunctive seizure control in this severe childhood epilepsy.

• Lamotrigine inhibits voltage‑gated sodium channels, stabilizing neuronal membranes and decreasing the release of excitatory neurotransmitters such as glutamate. By limiting rapid neuronal firing, it reduces the propagation of epileptiform activity and modulates mood‑regulating pathways, contributing to its antiepileptic and mood‑stabilizing effects. The drug’s selective action on sodium channels spares normal neuronal function while attenuating pathological hyperexcitability, which underlies its therapeutic profile in both seizure control and bipolar disorder management.

Lamotrigine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Dizziness: sensation of light‑headedness or unsteadiness.
• Headache: mild to moderate cranial pain.
• Nausea: feeling of stomach upset or urge to vomit.
• Rash: mild skin redness or itching.
• Blurred vision: temporary visual disturbances.
• Fatigue: unusual tiredness or lack of energy.

Serious or Rare Side Effects

• Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.
• Toxic epidermal necrolysis: extensive skin detachment requiring urgent care.
• Blood dyscrasias: aplastic anemia, agranulocytosis, or leukopenia.
• Hepatic failure: signs of liver injury such as jaundice.
• Suicidal thoughts: emergence of depressive ideation or suicidal behavior.
• Severe skin reactions: drug reaction with eosinophilia and systemic symptoms (DRESS).

When prescribing Lamotrigine, clinicians should consider several precautionary measures to minimize risks.

• Titrate dose: increase gradually to reduce rash risk.
• Monitor skin: watch for any rash, especially in the first weeks.
• Avoid abrupt discontinuation: taper to prevent seizure recurrence.
• Use caution in hepatic impairment: adjust dosing as needed.
• Review concomitant valproate: anticipate increased lamotrigine levels.
• Store at ambient temperature: keep in original packaging, protect from moisture and light.

Lamotrigine interacts with several medicines that can alter its plasma concentration or efficacy.

Major Interactions (Avoid)

• Valproate: markedly increases lamotrigine levels, requiring dose reduction.
• Carbamazepine: significantly reduces lamotrigine concentrations, potentially decreasing effectiveness.
• Phenytoin: lowers lamotrigine exposure, risking loss of seizure control.

Moderate Interactions (Monitor Closely)

• Phenobarbital: decreases lamotrigine levels, may need dose adjustment.
• Oral contraceptives: reduce lamotrigine efficacy, monitor seizure control.
• Serotonergic agents: may increase risk of serotonin syndrome, observe for symptoms.